Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned

被引：11

作者：

Benz, Alexander P. P. ^{[1
,2
,3
,4
]}

Eikelboom, John W. W. ^{[1
,2
]}

机构：

[1] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada

[2] McMaster Univ, Hamilton, ON, Canada

[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Cardiol, Mainz, Germany

[4] Populat Hlth Res Inst, 20 Copeland Ave, Hamilton, ON L8L 2X2, Canada

来源：

CIRCULATION | 2022年 / 146卷 / 23期

关键词：

Editorials; apixaban; atrial fibrillation; kidney failure; chronic; randomized controlled trial; warfarin; HEMODIALYSIS; STROKE;

D O I：

10.1161/CIRCULATIONAHA.122.061647

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1746 / 1748

页数：3

共 14 条

[1] Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial
De Vriese, An S.
Caluwe, Rogier
Van Der Meersch, Hans
De Boeck, Koen
De Bacquer, Dirk
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (06): : 1474 - 1483
[2] Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
De Vriese, An S.
Caluwe, Rogier
Pyfferoen, Lotte
De Bacquer, Dirk
De Boeck, Koen
Delanote, Joost
De Surgeloose, Didier
Van Hoenacker, Piet
Van Vlem, Bruno
Verbeke, Francis
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01): : 186 - 196
[3] Apixaban versus Warfarin in Patients with Atrial Fibrillation
Granger, Christopher B.
Alexander, John H.
McMurray, John J. V.
Lopes, Renato D.
Hylek, Elaine M.
Hanna, Michael
Al-Khalidi, Hussein R.
Ansell, Jack
Atar, Dan
Avezum, Alvaro
Cecilia Bahit, M.
Diaz, Rafael
Easton, J. Donald
Ezekowitz, Justin A.
Flaker, Greg
Garcia, David
Geraldes, Margarida
Gersh, Bernard J.
Golitsyn, Sergey
Goto, Shinya
Hermosillo, Antonio G.
Hohnloser, Stefan H.
Horowitz, John
Mohan, Puneet
Jansky, Petr
Lewis, Basil S.
Luis Lopez-Sendon, Jose
Pais, Prem
Parkhomenko, Alexander
Verheugt, Freek W. A.
Zhu, Jun
Wallentin, Lars
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
[4] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, Robert G.
Pearce, Lesly A.
Aguilar, Maria I.
[J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) : 857 - 867
[5] Hindricks G, 2021, EUR HEART J, V42, P546, DOI 10.1093/eurheartj/ehaa945
[6] Factor XI Inhibition to Uncouple Thrombosis From Hemostasis JACC Review Topic of the Week
Hsu, Charles
Hutt, Edward
Bloomfield, Daniel M.
Gailani, David
Weitz, Jeffrey I.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (06) : 625 - 631
[7] January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI [10.1161/CIR.0000000000000665, 10.1016/j.jacc.2019.01.011]
[8] Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
Olesen, Jonas Bjerring
Lip, Gregory Y. H.
Kamper, Anne-Lise
Hommel, Kristine
Kober, Lars
Lane, Deirdre A.
Lindhardsen, Jesper
Gislason, Gunnar Hilmar
Torp-Pedersen, Christian
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07) : 625 - 635
[9] Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
Pokorney, Sean D.
Chertow, Glenn M.
Al-Khalidi, Hussein R.
Gallup, Dianne
Dignacco, Pat
Mussina, Kurt
Bansal, Nisha
Gadegbeku, Crystal A.
Garcia, David A.
Garonzik, Samira
Lopes, Renato D.
Mahaffey, Kenneth W.
Matsuda, Kelly
Middleton, John P.
Rymer, Jennifer A.
Sands, George H.
Thadhani, Ravi
Thomas, Kevin L.
Washam, Jeffrey B.
Winkelmayer, Wolfgang C.
Granger, Christopher B.
[J]. CIRCULATION, 2022, 146 (23) : 1735 - 1745
[10] Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction
Potpara, Tatjana S.
Ferro, Charles J.
Lip, Gregory Y. H.
[J]. NATURE REVIEWS NEPHROLOGY, 2018, 14 (05) : 337 - 351

← 1 2 →